Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)

Preclinical models have demonstrated the efficacy of granulocyte-macrophage colony-stimulating factor-secreting cancer immunotherapies (GVAX platform) accompanied by immunotherapy-primed lymphocytes after autologous stem cell transplantation in hematologic malignancies. We conducted a phase 2 study...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Borrello, Ivan M., Levitsky, Hyam I., Stock, Wendy, Sher, Dorie, Qin, Lu, DeAngelo, Daniel J., Alyea, Edwin P., Stone, Richard M., Damon, Lloyd E., Linker, Charles A., Maslyar, Daniel J., Hege, Kristen M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2009
Pynciau:
Clinical Trials and Observations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738565/
https://ncbi.nlm.nih.gov/pubmed/19556425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-205278
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg